Life Sciences

The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

Liberty Leaf Holdings Ltd. is a new, Canadian-based, public company whose objective is to be at the forefront of the medicinal and recreational cannabis industry...accelerating revenue-generating businesses within this dynamic and fast-growing sector.

MedMen Enterprises is the preeminent cannabis company in the U.S. and the most recognized brand in the emerging marijuana industry, with assets and operations in California, Nevada and New York. Based in Los Angeles, MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry. MedMen is also one of the nation’s largest financial supporters of progressive marijuana legalization efforts at local, state and federal levels.